# K080990: Depuy Global C.AP. Cta Resurfacing Shoulder

- Pathway: 510(k) (Traditional)
- Applicant: DePuy Orthopaedics, Inc.
- Decided: Aug 8, 2008 after 123 days
- Product code: HSD (Prosthesis, Shoulder, Hemi-, Humeral, Metallic Uncemented)
- Device class: 2
- Regulation: 21 CFR 888.3690
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K800494 (1980). 28 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 31 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K000575: Global Advantage Extended Humeral Head, DePuy Orthopaedics, Inc. (2000) Summary page 1.
- K051843: Copeland Eas Humeral Resurfacing Heads, Biomet, Inc. (2005) Summary page 1.
- K073331: Dvo Extended Articulation Humeral Heads, Dvo Extremity Solutions, LLC (2008) Summary page 1.
- K031971: Global Cap Resurfacing Replacement Shoulder, DePuy Orthopaedics, Inc. (2003) Summary page 1.
- K010827: Copeland MB/HA Resurfacing Humeral Heads, Biomet Orthopedics, Inc. (2001) Summary page 1.

## Most influential descendants
- K203230: Global Shoulder and Delta CTA systems (2021), 0 descendants of its own
- K112900: SMR Resurfacing Shoulder System- Humeral Heads, Cta Humeral Heads (2012), 0 descendants of its own

## Indications for use
The DePuy Global C.A.P. CTA Resurfacing Shoulder is indicated for hemi-shoulder replacement in patients with rotator cuff tears and arthritis. Specific indications include: 1. Rotator cuff tear arthropathy. 2. Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate. CAUTION: The DePuy Global C.A.P. CTA Resurfacing Shoulder is intended for cementless use only.

Source page: https://510kreport.com/device/K080990
Methodology: https://510kreport.com/methodology